Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection: A Prospective, Multi-center, Single Arm, Objective Performance Criteria Clinical Trial

NCT04918212 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.

NCT NCT04918212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection: A Prospective, Multi-center, Single Arm, Objective Performance Criteria Clinical Trial
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 25, 2017
Completion date
October 13, 2020
Enrollment
148 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

aortic dissection type b